Incresync
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
Name | Incresync |
---|---|
Active Substance | alogliptinbenzoat pioglitazonklorid |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
ATC Code | A10BD09 |
Medicinal product marketed in the Croatia | Da |
Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
Link to the European Medicines Agency's (EMA) product information | download |
Link to the European Commission's (EC) decisions | download |